Brief: Axogen Initiates License Application To US FDA For Avance Nerve Graft®

AxoGen

16/05/2024 12:03

May 16 (Reuters) - AxoGen Inc  AXGN.O :
    * AXOGEN INC. INITIATES ROLLING SUBMISSION OF BIOLOGICS
LICENSE
APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR
AVANCE NERVE GRAFT®
    * AXOGEN INC - ANTICIPATE BLA FILING TO BE COMPLETED IN Q3
OF 2024
    * AXOGEN INC - BELIEVE PROCEDURAL TIMELINES FOR REVIEW
COMBINED
WITH ROLLING SUBMISSION PROCESS WILL ALLOW FOR APPROVAL AROUND
MID-2025

Source text for Eikon:  ID:nGNX224mlW 
Further company coverage:  AXGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))